![](https://investorshub.advfn.com/uicon/19649.png?cb=1607617291)
Tuesday, April 27, 2021 9:26:21 AM
The vaccines have given this false impression, and it is the common spoken word.
In my opinion, this is ridiculous.
Case counts are higher today than ever.
A high percentage of people are refusing the vaccines.
The vaccines’ length of efficacy is entirely unknown.
SARS-CoV-2 has mutated with variants, as viruses do, from the start, and is likely a long term, if not permanent, issue.
I initially viewed investing in Relief or NeuroRx as a short term play.
Now, I believe the opposite is true. When COPD is talked about in conjunction with RLF-100 (and ARDS in general), this has become a long term investment with a great amount of future potential.
Patience will be rewarded.
~ Money Making Money ~
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM